Analystreport

vTv Therapeutics Inc. (NASDAQ: VTVT) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $35.00 price target on the stock.

vTv Therapeutics Inc. - Class A  (VTVT) 
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vtvtherapeutics.com